341
On 16th of December 2005 a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 332. The active ingredient is 1,2-bis(methylsulphonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl”>hydrazine for treatment of acute myeloid leukaemia.